Subject: Prognostic factors of progression of osteoarthritis of the knee: A systematic review of observational studies



Volume 57, Issue 1, Pages 13-26

Published Online: 31 Jan 2007

Copyright © 2007 American College of Rheumatology




View Full Width

 

 

 Original Article

Prognostic factors of progression of osteoarthritis of the knee: A systematic review of observational studies


J. N. Belo *, M. Y. Berger, M. Reijman, B. W. Koes, S. M. A. Bierma-Zeinstra

Erasmus Medical Center, Rotterdam, The Netherlands

email: J. N. Belo (j.belo@erasmusmc.nl)

*Correspondence to J. N. Belo, Erasmus Medical Center Rotterdam, Department of General Practice, PO Box 2040, 3000 CA, Rotterdam, The Netherlands


Keywords

Osteoarthritis • Knee • Progression • Prognostic factors • Systematic review


Abstract

 

 

 

 

 

 

 


Objective

To provide an overview of prognostic factors of knee osteoarthritis (OA) progression.


Methods

We searched Medline and Embase up to December 2003 according to a specified search strategy (keywords for disease, location, and study design). Studies that fulfilled predefined criteria were assessed for methodologic quality. Study characteristics and associations were extracted and the results were summarized according to a best evidence synthesis.


Results

Of the 1,004 studies found, 37 met the inclusion criteria. Methodologic quality was assessed and only high-quality studies were included (n = 36). The best evidence synthesis yielded strong evidence that hyaluronic acid serum levels and generalized OA are predictive for progression of knee OA. Sex, knee pain, radiologic severity, knee injury, quadriceps strength, and regular sport activities were not predictive. Conflicting evidence for associations was found for several factors including body mass index and age. Limited evidence for an association with progression of knee OA was found for several factors, including the alignment (varus/valgus) of the joint. Limited evidence for no association with progression of OA was also found for several factors, including meniscectomy, several markers of bone or cartilage turnover, and the clinical diagnosis of localized OA.


Conclusion

Generalized OA and level of hyaluronic acid seem to be associated with the radiologic progression of knee OA. Knee pain, radiologic severity at baseline, sex, quadriceps strength, knee injury, and regular sport activities seem not to be related. For other factors, the evidence was limited or conflicting.


Received: 28 June 2005; Accepted: 4 April 2006


Digital Object Identifier (DOI)


10.1002/art.22475  About DOI


Article Text



INTRODUCTION

 

 

 

 

 

 

 

Radiographic osteoarthritis (OA) of the knee affects more than 33% of persons age 60 years and older, whereas 10-15% of persons age 60 years and older have symptomatic knee OA in which symptoms are defined as knee pain on most days ([1]). Because of aging of the population, the prevalence of OA is expected to increase in the next decades ([2]); in western countries, the increase in prevalence in the next 20 years is expected to be around 40%, making OA the fourth leading cause of disability ([2][3]).

To optimize the management of OA, it is important to increase our knowledge regarding the predictors of progression of OA. If certain prognostic factors are modifiable, they may enhance our ability to reduce OA progression. Even if these prognostic factors are not modifiable, they can still be used to identify high-risk groups, which may have implications for patient information and the perspective of medical treatment ([4]). Knowledge about modifiable factors and high-risk groups is also relevant for clinical research, such as for evaluating therapeutic interventions including disease-modifying therapies.

Several original studies have reported on prognostic factors of knee OA progression. Until now, however, a systematic overview of the determinants of progression of knee OA has not been available. To gain insight into the prognostic factors of progression of knee OA, we systematically reviewed the available studies on this topic using modern methods of identifying, assessing, and summarizing the available evidence.


MATERIALS AND METHODS

 

 

 

 

 

 

 


Identification of studies

To identify the observational studies on this subject, a search for relevant studies published up to December 2003 was performed in Medline and Embase. Key words used were knee, osteoarthritis (or arthritis, or arthrosis), prognostic (or progressive, or predictive, or precipitate), and case-control (or cohort, or retrospective, or prospective, or longitudinal, or followup). Screening the list of references of all identified relevant articles extended the search. A study was included when it fulfilled all of the following criteria: patients in the study had clinical or radiographic evidence of knee OA; the study investigated factors associated with the radiologic and/or clinical progression of knee OA; the followup period was at least 1 year; the study design was a prospective cohort or a nested case-control study; the article was written in English, Dutch, German, or French; full text was available for the article; and the study population had no underlying pathology (e.g., rheumatoid arthritis, bacterial infection) of the joint.


Methodologic quality

To assess the methodologic quality of the included articles, a scoring list was used (Table 1) based on the scoring lists used by Lievense et al ([5]) and Scholten-Peeters et al ([6]) and on the framework for assessing internal validity of articles dealing with prognosis as described by Altman ([7]). All studies were scored independently by 2 of the reviewers (JNB and MYB or MR). For each study, a total quality score was computed by counting all positively rated items (maximum score 13 points). In case of disagreement, both reviewers tried to achieve consensus. When consensus was not achieved, a third reviewer (BWK) was asked to give a final judgment.

 

Table 1. Criteria list for the methodologic assessment of study quality


Study population

   Description of source population

   Valid inclusion criteria

   Sufficient description of the baseline characteristics

Followup

   Followup at least 12 months

   Prospective data collection

   Loss to followup  20%

   Information about loss to followup

Exposure

   Exposure assessment blinded for the outcome

   Exposure measured identically in the studied population at baseline and/or followup

Outcome

   Outcome assessment blinded for exposure

   Outcome measured identically in the studied population at baseline and followup

Analysis

   Measure of association and measures of variance given

   Adjusted for age, sex, or severity




Data extraction

Study characteristics (followup duration, study population characteristics) were extracted and, when possible, the odds ratio (OR) or relative risk was provided or calculated. Otherwise, other measures of associations (hazard ratio, correlations) or values for statistical significance (P value) of the reported association were given.


Evidence synthesis

ORs or relative risks were statistically pooled when clinical and statistical homogeneity in several studies was assumed. In the absence of homogeneity, a best evidence synthesis was used to summarize the data.

The level of evidence was based on the guidelines of van Tulder et al ([8]) and was divided into the following levels: 1) strong evidence (consistent [>75%] findings among multiple [ 2] high-quality studies); 2) moderate evidence (findings in 1 high-quality study and consistent findings in multiple low-quality studies); 3) limited evidence (findings in 1 high-quality study or consistent findings in multiple low-quality studies); and 4) conflicting evidence (provided by conflicting findings [<75% of the studies reported consistent findings]). When strong evidence was provided only by studies with a small sample size, we decided to judge those studies as not strongly associated. Articles were judged as high quality when they had a quality score >8 (>60% of the maximal attainable score). Only statistically significant associations were considered as associated prognostic factors in the best evidence synthesis. When several radiologic outcomes for the progression of OA were provided, the best evidence synthesis was based on the increase in the Kellgren and Lawrence (K/L) score or the decrease in joint space width (JSW).


RESULTS

 

 

 

 

 

 

 


Studies included

Of the 1,004 articles identified using our search strategy, 37 articles met the criteria for inclusion. In the methodologic quality assessment, the 3 reviewers scored 520 items in total and agreed on 402 items (77%;   = 0.40). The 118 disagreements were resolved in a single consensus meeting. Almost all studies were of high quality and scored in the range of 9 to 12 (maximum score 13). One study (Sahlström et al [[9]]) scored 6 (<50%); because this was the only study of low quality, we excluded it from the analysis. An overview of the characteristics of the included studies (n = 36) is presented in Table 2.

 

Table 2. Study characteristics of the reviewed manuscripts*


Author (ref.), year

Additional study information

Followup, months

Definition OA for inclusion

Study population

Age, years

Women, %

No. of patients

Quality score


Cerejo ([10]), 2002

Subgroup of the MAK study

18

K/L

Elderly of the community

Mean ± SD 64 ± 10.8

73

230

12

Dieppe ([11]), 1997

The Bristol  OA 500  study

37.6

K/L

500 consecutive patients seen at a rheumatology clinic with peripheral joint symptoms attributable to radiographic evidence of OA at that joint site

65.3

68

415

12

Felson ([12]), 2003


15 and 30

OA Research Society International Atlas

Persons ages  45 years with symptomatic knee OA in the Veterans Administration hospital in Boston

Mean ± SD 66.2 ± 9.4

42

223

12

McAlindon ([13]), 1996

Framingham OA study

120

K/L

Population-based group followed for >40 years

70.3

63

556

12

Sharma ([14]), 2001

MAK study

18

K/L, JSW

Participants in MAK recruited: community-based study with senior citizens

Mean ± SD 64.0 ± 11.1

75

230

12

Spector ([15]), 1994

Chingford study (subsample)

24

K/L

Women with unilateral knee OA, population-based cohort

Mean ± SD 56.8 ± 5.9

100

58

12

Vilim ([16]), 2002

Subset of glucosamine trial (Pavelka)

36

K/L, JSW

Patients with symptomatic primary knee OA, part of a placebo arm of a 3-year trial

62.8 (range 48-74)

71

48

12

Bagge ([17]), 1992

Subsample of cohort

48

K/L

Population-based study of the elderly (75 years old) in Göteborg

-

57

74

11

Brandt ([18]), 1999


31.5 (range 23.0-6.2)

K/L

Independent community-based individuals, at least 65 years old, recruited from central Indiana by random digit dialing

Nonprogressive: women 71.6, men 72.4; progressive: women 70.1, men 72.7

70

82

11

Dieppe ([19]), 1993


60

Clinical and radiologic OA

Patients referred to a hospital-based rheumatology unit

Mean ± SD 62.2 ± 1.5

65

60

11

Dieppe ([20]), 2000

The Bristol  OA 500  study

96

K/L

500 consecutive patients seen at a rheumatology clinic with peripheral joint symptoms attributable to radiographic evidence of OA at that joint site

65.3

68

349

11

Ledingham ([21]), 1995


24 (range 12-60)

K/L

Consecutive patients attending a general rheumatologic clinic with symptomatic knee OA

71 (range 34-91)

63

188

11

Miyazaki ([22]), 2002


72

K/L, JSW

Patients ages >50 years with primary knee OA and knee pain in daily activities treated at an orthopedic unit

Mean ± SD 69.9 ± 7.8

81

74

11

Sharif ([23]), 1995


60

K/L

Patients referred to the Bristol Royal Infirmary Rheumatology

Mean ± SD 64.2 ± 11.6

69

75

11

Sharif ([24]), 1995


60

JSW

Hospital outpatients with clinical knee OA

Not provided

Not provided

57

11

Sharif ([25]), 2000


60

K/L

Hospital outpatients with clinical knee OA

Mean ± SD 65.2 ± 9.9

61

40

11

Zhang ([26]), 1998

Framingham OA study

96

K/L

Population-based group of women followed for >40 years

71 (range 63-91)

100

551

11

Zhang ([27]), 2000

Framingham OA study

96

K/L

Population-based group of women followed for >40 years

71 (range 63-91)

100

473

11

Bettica ([28]), 2002

Chingford study

48

Osteophytes and JSW

1,003 women, ages 45-64 years

Not provided

100

216

10

Cooper ([29]), 2000

Study based on population cohort

61.2

K/L

Men and women aged >55 years with knee pain, registered at a large general practice in Bristol

71.3

72

354

10

Doherty ([30]), 1996


30

K/L

135 consecutive patients referred to hospital with knee OA

71 (range 41-88)

56

134

10

Felson ([31]), 1995

Framingham OA study

Mean ± SD 97.2 ± 3.6

K/L

Population-based group followed for >40 years

Mean ± SD 70.8 ± 5.0

64

869

10

Fraenkel ([32]), 1998

Framingham OA study, nested case-control

48

K/L

Population-based group followed for >40 years

Not provided

67

423

10

Hart ([33]), 2002

Chingford study

48

Osteophytes and JSW

1,003 women, ages 45-64 years

Mean ± SD 54.1 ± 5.9

100

830

10

Lane ([34]), 1998


108

Osteophytes and JSW

Members of the 50-plus runners association of the US and a sample of the Stanford University Community

66

33

55

10

McAlindon ([35]), 1996

Framingham OA study

120

K/L

Population-based group followed for >40 years

70.3

64

640

10

Pavelka ([36]), 2000


60

K/L

Patients with primary OA undergoing evaluation for arthritis at the Prague Institute of Rheumatology, ages >40 years

Mean ± SD 59.1 ± 8.0

76

139

10

Schouten ([37]), 1992


Mean ± SD 146.4 ± 10.8

K/L

Population survey, study of several chronic diseases, especially rheumatic diseases, in Zoetermeer, The Netherlands, in persons ages  20 years

Mean ± SD 57.2 ± 6.1

59

239

10

Sharma ([38]), 2003

MAK

18

K/L

Community-based study with senior citizens

Mean ± SD 64.0 ± 11.1

74

171

10

Spector ([39]), 1992


132 (range 108-180)

K/L

Group 1: consecutive patients attending a rheumatology clinic with OA of the hand or knee; group 2: symptomatic patients with OA of the hand or knee enrolled in a short-term drug study

Group 1: 60, group 2: 61

Overall: 72

63

10

Spector ([40]), 1997

Chingford study

48

K/L

Women with unilateral knee OA, population-based cohort

Not provided

100

845

10

Sugiyama ([41]), 2003


48

JSW

Population-based survey, women ages 40-59 years with knee pain and early primary OA of the tibiofemoral joint

Mean ± SD 50.2 ± 6.0

100

110

10

Bruyere ([42]), 2003

Subjects part of a double-blind placebo-controlled study evaluating the effect of glucosamine sulfate

36

ACR criteria

Patients from the outpatient clinic of the Bone and Cartilage Metabolism Research Unit of the University Hospital Centre in Liege, Belgium

Mean ± SD 66.0 ± 7.3

76

157

9

Bruyere ([43]), 2003

Subjects part of a double-blind placebo-controlled study evaluating the effect of glucosamine sulfate

36

ACR criteria

Patients from the outpatient clinic of the Bone and Cartilage Metabolism Research Unit of the University Hospital Centre in Liege, Belgium

Mean ± SD 66.0 ± 7.3

76

157

9

Schouten ([44]), 1993


Mean ± SD 146.4 ± 10.8

K/L

Population survey, study of several chronic diseases, especially rheumatic diseases, in Zoetermeer, The Netherlands, in persons ages  20 years

Mean ± SD 57.4 ± 6.34

59

239

9

Wolfe ([45]), 2002


Mean ± SD 31.2 ± 48 and 102 ± 99.6

ACR criteria

Consecutive patients with OA of the knee or hip seen for clinical care at the Arthritis Center, Kansas

Mean ± SD 63.41 ± 11.77

77

583

9


   OA = osteoarthritis; MAK = Mechanical Factors in Arthritis of the Knee; K/L = Kellgren and Lawrence; JSW = joint space width; ACR = American College of Rheumatology.


All studies had a prospective research design. The studied populations were either population or hospital based. For the definition of OA, most studies used the Kellgren and Lawrence criteria or JSW. One study ([12]) used the Osteoarthritis Research Society International Atlas for the definition of OA, and another study ([19]) used the presence of clinical and radiologic OA. All studied populations, except 2 ([12][34]), contained more women than men. Progression was defined as radiologic progression in almost all studies. Only 4 studies ([11][19][23][24][45]) (15%) also reported on a clinical outcome (total knee replacement).


Study results

An overview of the potential prognostic factors and their relationship to the progression of radiologic OA is presented in Tables 3, 4, 5, and 6 and is summarized below.

 

Table 3. Systemic factors discussed in the reviewed studies*


Determinant

Author (ref.), year

Instrument of measurement

Definition of progression of OA

Outcome (95% CI) 


Age

Bagge ([17]), 1992

Dichotomous

Increase K/L grade  1

Not associated 


Dieppe ([19]), 1993


JSN  2 mm

Not associated 


Felson ([31]), 1995


Increase in K/L grade 2 to  3

Not associated 


Miyazaki ([22]), 2002

Continuous in years

JSN >1 grade on a 4-grade scale

OR 1.22 (1.05-1.41)


Schouten ([37]), 1992

Fourth quartile vs first

Change in JSW  -1 on a 9-point scale-4 to +4

OR 3.84 (1.10-13.4)


Wolfe ([45]), 2002

Continuous in years

JSN score = 3 (maximal score on a 4-point scale)

HR 1.00 (0.98-1.02)

Female sex

Dieppe ([19]), 1993


JSN  2 mm

Not associated 


Felson ([31]), 1995


Increase in K/L grade 2 to  3

RR 1.43 (0.80-2.58)


Ledingham ([21]), 1995


Increase in K/L grade, change in JSW, osteophytes, sclerosis, attrition, cutoff points not provided

Not associated 




Change in cyst size/number

OR 2.17 (1.13-4.15)


Miyazaki ([22]), 2002


JSN >1 grade on a 4-grade scale

OR 2.14 (0.34-13.50)


Schouten ([37]), 1992


Change in joint space  -1 on a 9-point scale-4 to +4

OR 0.50 (0.22-1.11)


Spector ([39]), 1992


Change of  1 grade JSN on a 4-point scale or  10% reduction in JSW

P = 0.3


Wolfe ([45]), 2002


JSN score = 3 (maximal score on a 4-grade scale)

HR 0.73 (0.44-1.19)

Low bone density

Hart ([33]), 2002

Low vs high

Change of  1 grade of JSN on a 4-point scale

Not associated 


Zhang ([27]), 2000

BMD changes -0.04-0 vs <-0.04 gm/cm2

Increase of  1 grade in K/L score (baseline K/L  2)

OR 0.4 (0.1-1.2)



BMD changes >0 vs <-0.04 g/cm2


OR 0.3 (0.1-0.8)



Second quartile vs first


OR 0.3 (0.1-0.9)



Third quartile vs first


OR 0.2 (0.1-0.6)



Fourth quartile vs first


OR 0.1 (0.03-0.3)

IGF-1

Fraenkel ([32]), 1998

Third tertile vs first in women

Increase of  1 grade on K/L score (baseline K/L  2)

OR 0.9 (0.5-1.6)



Third tertile vs first in men


OR 0.9 (0.3-3.0)


Schouten ([44]), 1993

Third tertile vs first

Change  2 overall score of changes of radiographic signs of OA on a 5-point scale

OR 2.58 (1.01-6.60)

Estrogen

Zhang ([26]), 1998

Past estrogen use vs never use

Increase of  1 grade on K/L score (baseline K/L  2)

OR 0.9 (0.6-1.4)



Current estrogen use vs never use


OR 0.4 (0.1-1.5)

Uric acid concentration

Schouten ([37]), 1992

Highest vs lowest tertile

Change in JSW  -1 on a 9-point scale-4 to +4

OR 1.36 (0.46-4.02)



Middle vs lowest tertile


OR 1.05 (0.36-3.00)


  * OA = osteoarthritis; 95% CI = 95% confidence interval; K/L = Kellgren and Lawrence; JSN = joint space narrowing; OR = odds ratio; JSW = joint space width; HR = hazard ratio; RR = relative risk; BMD = bone mass density; IGF-1 = insulin-like growth factor 1.

    All outcomes were adjusted for age and sex (if applicable).

    No OR with 95% CI or P value provided.

 

Table 4. Disease characteristics discussed in the reviewed studies*


Determinant

Author (ref.), year

Instrument of measurement

Definition of progression of OA

Outcome (95% CI) 


Knee pain

Cooper ([29]), 2000

Present vs absent

Increase in  1 grade K/L score (baseline K/L  1)

OR 0.8 (0.4-1.7)




Increase in  1 grade K/L score (baseline K/L  2)

OR 2.4 (0.7-8.0)


Dieppe ([19]), 1993

Present vs absent

JSN  2 mm

Not associated 


Miyazaki ([22]), 2002

Present vs absent

JSN  1 grade on a 4-grade scale

OR 0.93 (0.78-1.11)


Spector ([39]), 1992

Present vs absent

Change of  1 grade JSN on a 4-point scale or 10% reduction in JSN

P = 0.2


Wolfe ([45]), 2002

Present vs absent

JSN score = 3 (maximal score on a 4-grade scale)

HR 1.55 (1.07-2.24)

Markers bone/cartilage turnover





   Hyaluronic acid (serum)

Bruyere ([42]), 2003

High serum level vs low

Change in mean JSW, cutoff point not provided

P = 0.02


Sharif ([23]), 1995

High serum level vs low

JSN  2 mm or knee joint surgery

P = 0.007


Sharif ([25]), 2000

High serum level vs low

JSN  2 mm or knee joint surgery

OR 2.32 (1.16-4.66)

   Keratan sulfate (serum)

Bruyere ([42]), 2003

High serum level vs low

Change in mean JSW, cutoff point not provided

P = 0.02


Sharif ([23]), 1995

High serum level vs low

JSN  2 mm or knee joint surgery

P = 0.539

   COMP (serum)

Bruyere ([42]), 2003

High serum level vs low

Change in mean JSW, cutoff point not provided

Not associated 


Sharif ([24]), 1995

High serum level vs low

JSN  2 mm or knee joint surgery

P < 0.001


Vilim ([16]), 2002

High serum level vs low

JSN >0.5 mm

P < 0.05

Severity





   Radiologic severity

Bruyere ([43]), 2003

Radiographic severity, high vs low

JSN  0.5 mm

RR 2.39 (0.99-5.79)


Miyazaki ([22]), 2002

JSW, >3 mm vs <3 mm

JSN  1 grade on a 4-point scale

OR 0.74 (0.25-2.19)


Ledingham ([21]), 1995

Change in  1 radiographic feature vs no change

Change in attrition, cutoff point not provided

OR 1.72 (1.36-2.19)



Increase in K/L score or change in JSW, cutoff points not provided

Not associated 


Pavelka ([36]), 2000

JSN, continuous variable

Change in K/L grade  1

Not associated 


Wolfe ([45]), 2002

Initial JSN score, high vs low

JSN score = 3 (maximal score on a 4-point scale)

HR 2.62 (2.03-3.40)

   Clinical severity

Dieppe ([11]), 1997

Change in Steinbrocker grade (functional status)

Change  2 mm joint space and change in grade of sclerosis or osteophytes

P = 1.0


Wolfe ([45]), 2002

Global severity, continuous variable

JSN score = 3 (maximal score on a 4-point scale)

HR 1.02 (1.01-1.03)



HAQ disability, high vs low


HR 1.34 (0.93-1.93)

Heberden's nodes

Cooper ([29]), 2000


Increase of  1 grade on K/L score (baseline K/L  1)

OR 0.7 (0.4-1.6)




Increase of  1 grade on K/L score (baseline K/L  2)

OR 2.0 (0.7-5.7)


Schouten ([37]), 1992

Presence of Heberden's nodes at baseline

Change in JSW  -1 on a 9-point scale-4 to +4

OR 5.97 (1.54-23.1)

Osteoarthritis

Ledingham ([21]), 1995

Multiple joint OA vs local joint OA

Increase in K/L grade, cutoff point not provided

OR 2.39 (1.16-4.93)




Change in attrition

OR 2.42 (1.02-5.77)




Change in JSW, osteophytes, cyst, sclerosis, cutoff points not provided

Not associated 


Schouten ([37]), 1992

Clinical diagnosis of generalized OA by physical examination

Change in JSW  -1 on a 9-point scale-4 to +4

OR 3.28 (1.30-8.27)



Clinical diagnosis of localized OA by physical examination


OR 1.17 (0.51-2.72)

Duration of symptoms

Dieppe ([19]), 1993


JSN  2 mm

Not associated 


Wolfe ([45]), 2002

Continuous in years

JSN score = 3 (maximal score on a 4-point scale)

HR 1.03 (1.00-1.05)

CRP#

Sharif ([25]), 2000

Continuous variable

JSN  2 mm or knee joint surgery

OR 1.12 (0.81-1.55)


Spector ([40]), 1997

Continuous variable

Increase K/L grade  1

P = 0.006


  * COMP = cartilage oligomeric matrix protein; HAQ = Stanford Health Assessment Questionnaire; CRP = C-reactive protein; see Table 3 for additional definitions.

    All outcomes were adjusted for age and sex (if applicable).

    No OR and 95% CI or P value provided.

 

Table 5. Intrinsic factors discussed in the reviewed studies*


Determinant

Author (ref.), year

Analysis of determinant

Definition of progression of OA

Outcome OR (95% CI) 


Alignment

Cerejo ([10]), 2002

Varus vs nonvarus in K/L grade 0-1

Increase >1 grade JSN on a 4-point scale

2.50 (0.67-9.39)



Varus vs nonvarus in K/L grade 2


4.12 (1.92-8.82)



Varus vs nonvarus in K/L grade 3


10.96 (3.10-37.77)



Valgus vs nonvalgus in K/L grade 2


2.46 (0.95-6.34)



Valgus vs nonvalgus in K/L grade 3


10.44 (2.76-39.49)


Miyazaki ([22]), 2002

Varus vs nonvarus

Increase  1 grade in JSN on a 4-point scale

0.90 (0.66-1.23) 


Sharma ([14]), 2001

Varus vs nonvarus

Increase  1 grade in JSN on a 4-point scale

4.09 (2.20-7.62)



Varus vs neutral/mild valgus


2.98 (1.51-5.89)



Valgus vs nonvalgus


4.89 (2.13-11.20)



Valgus vs neutral/mild varus


3.42 (1.31-8.96)

Adduction moment

Miyazaki ([22]), 2002

 5 vs <5

Increase  1 grade JSN on a 4-point scale

6.46 (2.40-17.45)

Knee injury

Cooper ([29]), 2000

Yes vs no

Increase of  1 grade K/L score (baseline K/L  1)

1.2 (0.5-3.0)




Increase of  1 grade K/L score (baseline K/L  2)

1.1 (0.3-4.4)


Schouten ([37]), 1992

Injury knee joint, yes vs no

Change in joint space  -1 on a 9-point scale-4 to +4

2.62 (0.93-7.36)



Sport injury, yes vs no


0.62 (0.17-2.19)

Meniscectomy

Schouten ([37]), 1992

Yes vs no

Change in joint space  -1 on a 9-point scale-4 to +4

2.28 (0.57-9.03)

Chondrocalcinosis

Schouten ([37]), 1992

Yes vs no

Change in joint space  -1 on a 9-point scale-4 to +4

2.01 (0.55-7.42)


  * See Table 3 for definitions.

    All outcomes were adjusted for age and sex (if applicable).

    Univariate analysis OR = 3.10 (95% CI 1.07-9.12).

 

Table 6. Extrinsic factors discussed in the reviewed studies*


Determinant

Author (ref.), year

Analysis of determinant

Definition of progression of OA

Outcome (95% CI) 


Body mass index

Cooper ([29]), 2000

Highest tertile vs lowest

Increase of  1 grade K/L score (baseline K/L  1)

OR 2.6 (1.0-6.8)



Highest tertile vs lowest

Increase of  1 grade K/L score (baseline K/L  2)

OR 1.3 (0.3-5.0)


Dieppe ([19]), 1993

Continuous variable


Not associated 


Ledingham ([21]), 1995

Continuous variable

Change in joint space, cutoff point not provided

OR 1.07 (1.02-1.14)




Change in osteophytes, cutoff point not provided

OR 1.06 (1.00-1.12)




Change in K/L grade, cyst, attrition, cutoff points not provided

Not associated 


Miyazaki ([22]), 2002

Continuous variable


OR 1.21 (0.91-1.61)


Schouten ([37]), 1992

Second quartile vs first

Change in joint space  -1 on a 9-point scale-4 to +4

OR 1.77 (0.48-6.50)



Third quartile vs first


OR 5.28 (1.54-18.1)



Fourth quartile vs first


OR 11.1 (3.28-37.3)


Spector ([15]), 1994

Third vs first tertile

Increase in K/L score or JSN, cutoff point not provided

RR 4.69 (0.63-34.75)


Wolfe ([45]), 2002

Continuous variable

JSN score = 3

HR 1.03 (1.00-1.06)

Quadriceps strength

Brandt ([18]), 1999

Progressive vs nonprogressive group§

Increase  1 grade K/L score

Not associated 


Sharma ([38]), 2003

Higher vs lower quadriceps strength§

Increase  1 grade JSN

P = 0.09

Running

Lane ([34]), 1998

Dichotomous

Increase  1 grade of score based on JSW, osteophyte formation and subchondral sclerosis

Not associated 


Schouten ([37]), 1992

Dichotomous§

Change in joint space  -1 on a 9-point scale-4 to +4

OR 0.53 (0.17-1.68)

Regular sport

Cooper ([29]), 2000

Dichotomous§

Increase of  1 grade K/L score (baseline K/L  1)

OR 0.7 (0.4-1.6)




Increase of  1 grade K/L score (baseline K/L  2)

OR 0.9 (0.3-2.5)


Schouten ([37]), 1992

Physical activity: highest vs lowest level

Change in joint space  -1 on a 9-point scale-4 to +4

OR 0.43 (0.11-1.76)



Walking: highest vs lowest level


OR 1.47 (0.36-6.03)



Standing: medium vs lowest level


OR 3.80 (1.03-13.96)



Standing: highest vs lowest level


OR 2.09 (0.43-10.31)

Nutrition variables

McAlindon ([13]), 1996

Vitamin D (dietary intake): middle tertile vs highest

Increase of  1 grade JSN score

OR 2.99 (1.06-8.49)



Vitamin D (serum levels): middle tertile vs highest


OR 2.83 (1.02-7.85)


McAlindon ([35]), 1996

Vitamin C intake: middle tertile vs lowest

Increase of  1 grade K/L score

OR 0.32 (0.14-0.77)



 -carotene intake: highest tertile vs lowest


OR 0.42 (0.19-0.94)



Vitamin E intake: middle tertile vs lowest


OR 0.44 (0.19-1.00)



Vitamin E intake: highest tertile vs lowest


OR 0.68 (0.28-1.64)

Smoking

Schouten ([37]), 1992

Smoked in past vs never smoked

Change in joint space  -1 on a 9-point scale-4 to +4

OR 1.07 (0.38-3.04)



Current smoker vs never smoked


OR 0.96 (0.34-2.75)

Depression/anxiety

Wolfe ([45]), 2002

Depression, yes vs no

JSN score = 3

HR 1.09 (0.93-1.28)



Anxiety, yes vs no


HR 0.95 (0.84-1.08)


  * See Table 3 for definitions.

    All outcomes were adjusted for age and sex (if applicable).

    No OR with 95% CI or P value provided.

  § Assessed at baseline.

   Assessed at followup.



Systemic factors (Table 3).

Schouten et al ([37]) found a significant association between age and progression of knee OA only for the comparison of the fourth quartile (higher age) versus the first quartile (lower age). In their study, there was no significant association reported for the second and third quartile versus the first quartile. Miyazaki et al ([22]) also found a significant association between age and progression of knee OA. Bagge et al ([17]), Dieppe et al ([19]), and Felson et al ([31]) reported no significant association, but an OR or P value was not provided. Wolfe and Lane ([45]) also found no significant association.

Although no ORs or P values were given, Dieppe et al ([19]) and Felson et al ([31]) reported no significant association between sex and progression of knee OA. Ledingham et al ([21]) reported an association between sex and the change in cyst number but not between sex and change in K/L grade or joint space narrowing (JSN). Miyazaki et al ([22]), Schouten et al ([37]), Spector et al ([39]), and Wolfe and Lane ([45]) found no significant association between sex and progression of knee OA.

Hart et al ([33]) reported no statistically significant difference in bone density between the nonprogressive group and the progressive group (OR or P value not provided). In contrast, Zhang et al ([27]) found an association between high versus low bone density and progression of knee OA (fourth versus first quartile OR 0.1, 95% confidence interval [95% CI] 0.03-0.3). The difference in progression of knee OA for the change in bone density of the lowest versus the second lowest group was not significant.

For insulin-like growth factor 1 (IGF-1), Schouten et al ([37]) found a significant association between progression of knee OA in the third versus the first tertile only. No significant association was found for the second versus the first tertile. Fraenkel et al ([32]) found no association between IGF-1 and progression of knee OA in the comparison of the third tertile versus the first; they also found no significant association for the comparison between men and women of the second tertile versus the first tertile.

Zhang et al ([26]) investigated the relationship between estrogen use and radiologic progression of knee OA. No significant association was found between current use, past use, or never use of estrogen and progression of knee OA. Schouten et al ([37]) found no association between uric acid concentration and progression of knee OA.


Disease characteristics (Table 4).

Only the study by Wolfe and Lane ([45]) found a significant relationship between knee pain at baseline and progression of knee OA. Dieppe et al ([19]) also investigated the relationship between knee pain at baseline and a subsequent operation of the knee, and found a significant association (P   0.001).

For markers of bone or cartilage turnover, Bettica et al ([28]) found a relationship between the level of type I collagen telopeptides in urine and progression of knee OA (P value not provided). One study by Bruyere et al ([42]) and 2 studies by Sharif et al ([23][25]) found a significant association between the level of hyaluronic acid in serum and progression of knee OA. Conflicting associations were found for the level of keratan sulfate and the level of cartilage oligomeric matrix protein (COMP). With regard to COMP, Bruyere et al ([42]) found no significant association (OR or P value not provided) in contrast to Sharif et al ([24]) and Vilim et al ([16]). Bruyere et al ([42]) found no significant associations between osteocalcin, pyridinoline, or deoxypyridinoline and progression of knee OA (OR or P values not provided). Doherty et al ([30]) found a statistically significant association for the level of inorganic pyrophosphate in the synovial fluid (OR 0.97, 95% CI 0.95-0.99). Ledingham et al ([21]) found a significant association between the presence of calcium pyrophosphate crystals and change in attrition of the knee joint (OR 2.41, 95% CI 1.33-4.39); the relationship of this determinant to progression in the K/L score or JSN was not provided. Sugiyama et al ([41]) found a significant association between the level of type II procollagen propeptide and progression of knee OA (P = 0.001).

Concerning severity of OA, only Wolfe and Lane ([45]) found a significant association between the initial JSW score and progression. Ledingham et al ([21]) found a significant association with the change in attrition; in their study, no association was found between radiologic severity and change in the K/L score or JSN. Contradictory associations were found in the relationship between clinical severity and progression of knee OA ([11][45]).

Whereas Schouten et al ([37]) reported a significant association with Heberden's nodes, Cooper et al ([29]) found no significant association.

Ledingham et al ([21]) and Schouten et al ([37]) both reported a significant positive association between the presence of generalized OA (radiologically and/or clinically determined) and progression of knee OA. The clinical diagnosis of local OA made by a physical examination was not related to radiologic progression of knee OA in the study by Schouten et al ([37]).

Dieppe et al ([19]) found no association with duration of symptoms (OR or P value not provided) and Wolfe and Lane ([45]) found a borderline significant association. In contrast to the significant relationship between C-reactive protein level (CRP) and progression of knee OA found by Spector et al ([40]), Sharif et al ([25]) did not find a significant association.

Ledingham et al ([21]) described synovial fluid volume and nodal warmth in relation to progression of knee OA. For synovial fluid volume as a continuous variable, a significant relationship was found (change in K/L score OR 1.03, 95% CI 1.01-1.05; change in attrition OR 1.80, 95% CI 1.00-1.05). With regard to nodal warmth in relation to change in K/L score, a significant relationship was found (OR 1.80, 95% CI 1.02-3.17).

Felson et al ([12]) found an association between medial bone marrow edema lesions versus no medial lesions in relation to progression of knee OA (OR 5.6, 95% CI 2.1-14.8). No association was found between lateral bone marrow edema lesions versus no lateral lesions in relation to progression.


Intrinsic factors (Table 5).

Three studies ([10][14][22]) reported a statistically significant association between varus alignment and progression of OA measured by a decrease in JSW. A nonsignificant relationship between the varus alignment and progression of OA was only found in the analysis of the K/L grade 0-1 group in the study by Cerejo et al ([10]). In the study by Miyazaki et al ([22]), a statistically significant OR was found for the univariate analysis of varus alignment and progression of knee OA (OR 3.10, 95% CI 1.07-9.12), but not in the multivariate analysis. Cerejo et al ([10]) and Sharma et al ([14]) also investigated the relationship between valgus alignment and progression of lateral knee OA. Both studies found a statistically significant relationship with progression of OA (valgus versus nonvalgus OR 10.44 and 4.89, respectively). Sharma et al ([14]) also compared varus with neutral/mild valgus and valgus with neutral/mild varus. In both comparisons, a statistically significant association was found (OR 2.98 and 3.42, respectively).

Miyazaki et al ([22]) also investigated the association between the adduction moment and progression of OA. For the adduction moment, a statistically significant association was reported.

Two studies reported the relationship between injury of the knee joint and progression of OA. Both studies found no statistically significant relationship. In the study by Cooper et al ([29]), the relationship between previous knee injury and progression of OA was investigated. In the study by Schouten et al ([37]), knee injury was assessed at followup. Schouten et al ([37]) also investigated the relationship between sport injury and progression of OA, but no statistically significant association was found.

For the relationship between meniscectomy and progression of OA, Schouten et al ([37]) found no statistically significant association. In the same study, the evaluated relationship between chondrocalcinosis and progression of knee OA was not statistically significant. Hart et al ([33]) investigated the relationship between the history of a fracture and the progression of OA, but no statistically significant relationship was found (OR or P value not provided).


Extrinsic factors (Table 6).

In the study by Cooper et al ([29]), a significant relationship with body mass index (BMI) was only found in the comparison of the highest tertile versus the lowest tertile in the group with baseline K/L grade 2 or higher. No statistically significant relationship was found in the comparison of the middle tertile versus the lowest tertile in the group with baseline K/L grade 1 or higher or grade 2 or higher (OR 2.3, 95% CI 0.8-6.4 and OR 1.8, 95% CI 0.4-8.2, respectively) and in the comparison of the highest versus the lowest tertile in the group with baseline K/L grade 1 or higher. The studies by Dieppe et al ([19]), Miyazaki et al ([22]), and Spector et al ([15]) found no statistically significant relationship between BMI and the progression of OA. Schouten et al ([37]) found a significant association in the 2 highest quartiles versus the lowest quartile. In the comparison of the second quartile versus the first quartile, no statistically significant association was found. Ledingham et al ([21]) only found a significant association for the relationship of BMI with JSN. In that study, a borderline significant association was found for the relationship with the change in osteophytes and no statistical association was found in the relationship between change in K/L grade. Wolfe and Lane ([45]) also found a borderline significant relationship between BMI and progression of OA. Spector et al ([15]) also investigated the relationship between change in BMI and progression of OA, but no statistically significant association was found (OR or P value not provided).

Two studies ([18][38]) investigated the relationship between quadriceps strength at baseline and progression of OA. Both studies found no statistically significant association.

Lane et al ([34]) and Schouten et al ([37]) investigated the relationship between running and progression of OA. In both studies, no statistically significant association was reported. In the study by Lane et al ([34]), running activities occurred during the followup period. In the study by Schouten et al ([37]), running was only assessed at baseline and no information about running during the followup period was presented.

Cooper et al ([29]) found no statistically significant association between regular sport activities assessed during followup and progression of OA (OR 0.7, 95% CI 0.4-1.6). Schouten et al ([37]) analyzed different types of activities. All of these activities were assessed at followup. For physical activity in general, no statistical association was found. For walking, squatting/kneeling/crawling, knee knocking, and lifting heavy objects, no statistically significant association was found. For standing, a significant association was only found in the comparison of the medium versus the lowest level. A statistically significant association was also found between bowing legs or knocking knees and the progression of OA.

McAlindon et al ([13][35]) investigated the relationship between nutrition variables and progression of OA. For vitamin D, a low dietary intake and low serum level were statistically and significantly associated with progression of knee OA (OR 4.05, 95% CI 1.40-11.6 and OR 2.89, 95% CI 1.01-8.25 for lowest versus highest tertile of dietary intake and serum levels, respectively). Also for vitamin C intake, a significant association was found (highest versus lowest tertile OR 0.26, 95% CI 0.11-0.61). A significant association was reported for  -carotene intake only in the comparison of the highest versus the lowest tertile (middle versus lowest OR 1.42, 95% CI 0.68-3.00). For vitamin E intake, a borderline significant association was found in the comparison of the middle versus the lowest tertile, but no statistically significant association was found for the highest versus the lowest tertile. For the relationship between progression of OA and the intake of vitamin B1, vitamin B6, niacin, and folate, no statistically significant relationship was found.

Schouten et al ([37]) reported no statistical association between smoking and progression of OA. Wolfe and Lane ([45]) investigated the relationship between depression and anxiety and progression of knee OA. For both factors, no statistically significant association was found. The same study also investigated the relationship between being a high school graduate and progression of knee OA, but no statistically significant association was found. In another study, Dieppe et al ([20]) reported a statistically significant relationship between the use of drugs (nonsteroidal antiinflammatory drugs [NSAIDs]) and the overall measure of change of OA (i.e., clinical improvement or worsening; P = 0.017 for improvement among users versus nonusers). Dieppe et al ([11]) also reported a statistically significant association between the use of walking aids and the clinical improvement of OA (P < 0.001).


Best evidence synthesis

Because of the heterogeneity of the reviewed studies, statistical pooling of the extracted data was not feasible. Therefore, we applied a best evidence synthesis. The best evidence synthesis demonstrated that, based on multiple high-quality studies, there seems to be strong evidence that the level of hyaluronic acid in serum and generalized OA are associated with radiologic progression of knee OA. Also based on multiple high-quality studies, there seems to be strong evidence that sex, knee injury, quadriceps strength, and regular sport activities are not associated, and that knee pain at baseline and radiologic severity of OA at baseline are not strongly associated with the radiologic progression of knee OA.

There is, as yet, limited evidence that there is a relationship between progression of knee OA and synovial fluid volume, nodal warmth, medial bone marrow edema lesions, adduction moment, alignment of the joint (varus/valgus), low serum levels and dietary intake of vitamin D, low intake of vitamin C, use of walking aids, and the use of drugs (NSAIDs). There also is limited evidence that there is no strong association between progression of knee OA and estrogen, uric acid concentration, clinical diagnosis of localized OA, the other markers of bone or cartilage turnover, lateral bone marrow edema lesions, meniscectomy, chondrocalcinosis, running, niacin, folate, smoking, depression or anxiety, being a high school graduate, and low intake of  -carotene, vitamin E, vitamin B1, and vitamin B6. Conflicting evidence is found in the relationship between progression of knee OA and age, bone density, IGF-1, Heberden's nodes, keratan sulfate, COMP, duration of symptoms, clinical severity, CRP level at baseline, and BMI.


DISCUSSION

 

 

 

 

 

 

 

There seems to be strong evidence that the presence of generalized OA and the level of hyaluronic acid in serum are predictors for radiologic progression of knee OA. There also seems to be strong evidence that sex, knee pain, radiologic severity at baseline, quadriceps strength, knee injury, and regular sport activities are not predictive. For the other studied factors, the evidence is limited or conflicting.

In this review, only significant associations were considered as associated prognostic factors in the best evidence synthesis. Several studies included small sample sizes, which implied low statistical power. For the factors with strong evidence for not being a predictor of OA progression, no associations were found in studies with both small and large sample sizes. For age, IGF-1, COMP, bone density, Heberden's nodes, and BMI, the conflicting associations could not be explained by the difference in sample size; however, the sample size might be an explanation for the conflicting findings for keratan sulfate, duration of symptoms, and the level of CRP.

Especially for the studies with small sample sizes, pooling of the data would have provided a more precise estimate of the association with the outcome. However, because of the heterogeneity of the setting of the studied populations and the differences in disease definition of the included studies, pooling of the data was not possible. Because of small sample sizes, we report instead that there seems to be strong evidence for no association rather than stating that there is no such association at all.

In the presented studies, OA at baseline was defined in different ways, including using the K/L scale, JSW, or radiologic and clinical characteristics of OA. In all determinants (except knee pain at baseline and the duration of symptoms) the conflicting findings are not likely to be explained by the difference in the definition of OA used.

In contrast to the review on prognostic factors of progression of hip OA by Lievense et al ([5]), we found only 4 studies (15%) that also used a clinical outcome for progression of knee OA ([11][19][23][24][45]). The study by Dieppe et al ([11]) did not include persons with a total knee replacement in the analysis; the other 4 studies used either a radiologic change or a total knee replacement in their definition for progression of knee OA ([19][23][24][45]). The numbers of patients with a total knee replacement in another study by Dieppe et al ([11]) (n = 415) and 2 studies by Sharif et al ([23][24]) (n = 75) were 12 and 14, respectively. In the study by Wolfe and Lane ([45]), the number of persons with a total knee replacement was not provided. Therefore, the present review mainly dealt with radiologic progression of knee OA and the conclusions cannot directly be applied to clinical progression of knee OA, whereas for clinical use it is of major interest to know the relationship between these factors and clinical progression of knee OA.

In contrast to the findings of radiologic severity as a predictor for progression of hip OA ([5]), we found evidence that radiologic severity hardly has predictive value for radiologic progression of knee OA. The reason for this difference may simply be that in the present review none of the studies reporting the relationship between radiologic severity and progression of knee OA used total knee replacement as an outcome measure, whereas in the review by Lievense et al ([5]) a total hip replacement was often used as an outcome, and radiologic severity was one of the indicators for a subsequent total hip or knee replacement ([46]).

Future research on the potential relationship between prognostic factors of radiologic progression of knee OA is needed. The factors where conflicting associations were found (e.g., BMI, age) especially need to be clarified. Furthermore, several factors were investigated in a single study only and provided limited evidence; replicated studies of these factors are needed.

Future study on clinical progression of knee OA is of major importance because of its implications for patient information and appropriate medical treatment. In the best evidence synthesis, in case of strong evidence for either the presence or the absence of an association, future scientific consensus is needed on how to summarize the evidence provided by studies with a small sample size. In summary, this review provides the currently available evidence, but also identifies the lack of data with respect to prognostic factors of progression of knee OA.


AUTHOR CONTRIBUTIONS

 

 

 

 

 

 

 

Dr. Belo had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Study design. Drs. Belo, Berger, Reijman, and Bierma-Zeinstra.

Acquisition of data. Drs. Belo and Bierma-Zeinstra.

Analysis and interpretation of data. Drs. Belo, Berger, Reijman, Koes, and Bierma-Zeinstra.

Manuscript preparation. Drs. Belo, Berger, Reijman, Koes, and Bierma-Zeinstra.

Statistical analysis. Dr. Belo.


References

 

 

 

 

 

 

 

1

Felson DT. An update on the pathogenesis and epidemiology of osteoarthritis [review]. Radiol Clin North Am 2004; 42: 1-9, v. Links  

2

Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ 2003; 81: 646-56. Links  

3

Schouten JS, Poos MJ, Gijsen R. Neemt het aantal mensen met artrose toe of af? In: Volksgezondheid toekomst verkenning, Nationaal Kompas Volksgezondheid. Bilthoven: RIVM; 2002.

4

Lohmander LS, Felson D. Can we identify a  high risk  patient profile to determine who will experience rapid progression of osteoarthritis? [review]. Osteoarthritis Cartilage 2004; 12 Suppl A: S49-52. Links  

5

Lievense AM, Bierma-Zeinstra SM, Verhagen AP, Verhaar JA, Koes BW. Prognostic factors of progress of hip osteoarthritis: a systematic review [review]. Arthritis Rheum 2002; 47: 556-62. Links  

6

Scholten-Peeters GG, Verhagen AP, Bekkering GE, van der Windt DA, Barnsley L, Oostendorp RA, et al. Prognostic factors of whiplash-associated disorders: a systematic review of prospective cohort studies. Pain 2003; 104: 303-22. Links  

7

Altman DG. Systematic reviews of evaluations of prognostic variables. BMJ 2001; 323: 224-8. Links  

8

Van Tulder M, Furlan A, Bombardier C, Bouter L, and the Editorial Board of the Cochrane Collaboration Back Review Group. Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group. Spine 2003; 28: 1290-9. Links  

9

Sahlstrom A, Johnell O, Redlund-Johnell I. The natural course of arthrosis of the knee. Clin Orthop Relat Res 1997; 340: 152-7. Links  

10

Cerejo R, Dunlop DD, Cahue S, Channin D, Song J, Sharma L. The influence of alignment on risk of knee osteoarthritis progression according to baseline stage of disease. Arthritis Rheum 2002; 46: 2632-6. Links  

11

Dieppe PA, Cushnaghan J, Shepstone L. The Bristol  OA500  study: progression of osteoarthritis (OA) over 3 years and the relationship between clinical and radiographic changes at the knee joint. Osteoarthritis Cartilage 1997; 5: 87-97. Links  

12

Felson DT, McLaughlin S, Goggins J, LaValley MP, Gale ME, Totterman S, et al. Bone marrow edema and its relation to progression of knee osteoarthritis. Ann Intern Med 2003; 139: 330-6. Links  

13

McAlindon TE, Felson DT, Zhang Y, Hannan MT, Aliabadi P, Weissman B, et al. Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham Study. Ann Intern Med 1996; 125: 353-9. Links  

14

Sharma L, Song J, Felson DT, Cahue S, Shamiyeh E, Dunlop DD. The role of knee alignment in disease progression and functional decline in knee osteoarthritis. JAMA 2001; 286: 188-95. Links  

15

Spector TD, Hart DJ, Doyle DV. Incidence and progression of osteoarthritis in women with unilateral knee disease in the general population: the effect of obesity. Ann Rheum Dis 1994; 53: 565-8. Links  

16

Vilim V, Olejarova M, Machacek S, Gatterova J, Kraus VB, Pavelka K. Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthritis Cartilage 2002; 10: 707-13. Links  

17

Bagge E, Bjelle A, Svanborg A. Radiographic osteoarthritis in the elderly: a cohort comparison and a longitudinal study of the  70-year old people in Goteborg.   Clin Rheumatol 1992; 11: 486-91. Links  

18

Brandt KD, Heilman DK, Slemenda C, Katz BP, Mazzuca SA, Braunstein EM, et al. Quadriceps strength in women with radiographically progressive osteoarthritis of the knee and those with stable radiographic changes. J Rheumatol 1999; 26: 2431-7. Links  

19

Dieppe P, Cushnaghan J, Young P, Kirwan J. Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy. Ann Rheum Dis 1993; 52: 557-63. Links  

20

Dieppe P, Cushnaghan J, Tucker M, Browning S, Shepstone L. The Bristol 'OA500 study': progression and impact of the disease after 8 years. Osteoarthritis Cartilage 2000; 8: 63-8. Links  

21

Ledingham J, Regan M, Jones A, Doherty M. Factors affecting radiographic progression of knee osteoarthritis. Ann Rheum Dis 1995; 54: 53-8. Links  

22

Miyazaki T, Wada M, Kawahara H, Sato M, Baba H, Shimada S. Dynamic load at baseline can predict radiographic disease progression in medial compartment knee osteoarthritis. Ann Rheum Dis 2002; 61: 617-22. Links  

23

Sharif M, George E, Shepstone L, Knudson W, Thonar EJ, Cushnaghan J, et al. Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum 1995; 38: 760-7. Links  

24

Sharif M, Saxne T, Shepstone L, Kirwan JR, Elson CJ, Heinegard D, et al. Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint. Br J Rheumatol 1995; 34: 306-10. Links  

25

Sharif M, Shepstone L, Elson CJ, Dieppe PA, Kirwan JR. Increased serum C reactive protein may reflect events that precede radiographic progression in osteoarthritis of the knee. Ann Rheum Dis 2000; 59: 71-4. Links  

26

Zhang Y, McAlindon TE, Hannan MT, Chaisson CE, Klein R, Wilson PW, et al. Estrogen replacement therapy and worsening of radiographic knee osteoarthritis: the Framingham Study. Arthritis Rheum 1998; 41: 1867-73. Links  

27

Zhang Y, Hannan MT, Chaisson CE, McAlindon TE, Evans SR, Aliabadi P, et al. Bone mineral density and risk of incident and progressive radiographic knee osteoarthritis in women: the Framingham Study. J Rheumatol 2000; 27: 1032-7. Links  

28

Bettica P, Cline G, Hart DJ, Meyer J, Spector TD. Evidence for increased bone resorption in patients with progressive knee osteoarthritis: longitudinal results from the Chingford Study. Arthritis Rheum 2002; 46: 3178-84. Links  

29

Cooper C, Snow S, McAlindon TE, Kellingray S, Stuart B, Coggon D, et al. Risk factors for the incidence and progression of radiographic knee osteoarthritis. Arthritis Rheum 2000; 43: 995-1000. Links  

30

Doherty M, Belcher C, Regan M, Jones A, Ledingham J. Association between synovial fluid levels of inorganic pyrophosphate and short term radiographic outcome of knee osteoarthritis. Ann Rheum Dis 1996; 55: 432-6. Links  

31

Felson DT, Zhang Y, Hannan MT, Naimark A, Weissman BN, Aliabadi P, et al. The incidence and natural history of knee osteoarthritis in the elderly: the Framingham Osteoarthritis Study. Arthritis Rheum 1995; 38: 1500-5. Links  

32

Fraenkel L, Zhang Y, Trippel SB, McAlindon TE, LaValley MP, Assif A, et al. Longitudinal analysis of the relationship between serum insulin-like growth factor-I and radiographic knee osteoarthritis. Osteoarthritis Cartilage 1998; 6: 362-7. Links  

33

Hart DJ, Cronin C, Daniels M, Worthy T, Doyle DV, Spector TD. The relationship of bone density and fracture to incident and progressive radiographic osteoarthritis of the knee: the Chingford Study. Arthritis Rheum 2002; 46: 92-9. Links  

34

Lane NE, Oehlert JW, Bloch DA, Fries JF. The relationship of running to osteoarthritis of the knee and hip and bone mineral density of the lumbar spine: a 9 year longitudinal study. J Rheumatol 1998; 25: 334-41. Links  

35

McAlindon TE, Jacques P, Zhang Y, Hannan MT, Aliabadi P, Weissman B, et al. Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis? Arthritis Rheum 1996; 39: 648-56. Links  

36

Pavelka K, Gatterova J, Altman RD. Radiographic progression of knee osteoarthritis in a Czech cohort. Clin Exp Rheumatol 2000; 18: 473-7. Links  

37

Schouten JS, van den Ouweland FA, Valkenburg HA. A 12 year follow up study in the general population on prognostic factors of cartilage loss in osteoarthritis of the knee. Ann Rheum Dis 1992; 51: 932-7. Links  

38

Sharma L, Dunlop DD, Cahue S, Song J, Hayes KW. Quadriceps strength and osteoarthritis progression in malaligned and lax knees. Ann Intern Med 2003; 138: 613-9. Links  

39

Spector TD, Dacre JE, Harris PA, Huskisson EC. Radiological progression of osteoarthritis: an 11 year follow up study of the knee. Ann Rheum Dis 1992; 51: 1107-10. Links  

40

Spector TD, Hart DJ, Nandra D, Doyle DV, Mackillop N, Gallimore JR, et al. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum 1997; 40: 723-7. Links  

41

Sugiyama S, Itokazu M, Suzuki Y, Shimizu K. Procollagen II C propeptide level in the synovial fluid as a predictor of radiographic progression in early knee osteoarthritis. Ann Rheum Dis 2003; 62: 27-32. Links  

42

Bruyere O, Collette JH, Ethgen O, Rovati LC, Giacovelli G, Henrotin YE, et al. Biochemical markers of bone and cartilage remodeling in prediction of longterm progression of knee osteoarthritis. J Rheumatol 2003; 30: 1043-50. Links  

43

Bruyere O, Honore A, Ethgen O, Rovati LC, Giacovelli G, Henrotin YE, et al. Correlation between radiographic severity of knee osteoarthritis and future disease progression: results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate. Osteoarthritis Cartilage 2003; 11: 1-5. Links  

44

Schouten JS, van den Ouweland FA, Valkenburg HA, Lamberts SW. Insulin-like growth factor-1: a prognostic factor of knee osteoarthritis. Br J Rheumatol 1993; 32: 274-80. Links  

45

Wolfe F, Lane NE. The longterm outcome of osteoarthritis: rates and predictors of joint space narrowing in symptomatic patients with knee osteoarthritis. J Rheumatol 2002; 29: 139-46. Links  

46

Dieppe P, Basler HD, Chard J, Croft P, Dixon J, Hurley M, et al. Knee replacement surgery for osteoarthritis: effectiveness, practice variations, indications and possible determinants of utilization. Rheumatology (Oxford) 1999; 38: 73-83. Links